$83.33 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 4

Data Bits

Data Bits Value / Change Benchmark
Job Posts 31 3.3%
Sentiment 57 0%
Webpage traffic 22,000 -4.4%
Employee Rating 91 0%
Google Adspend $18 -55%
Google Trends 7 -65%
Linkedin Employees 1,328 N/A
Patents 119 0%
4chan Mentions 0%
Facebook Engagement 334 0.9%
Facebook followers 8,971 0%
Stocktwits Mentions 5 0%
Stocktwits Subscribers 18,580 0%
Twitter Followers 5,264 0%
Instagram Followers 4,279 -0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 93 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Sarepta Therapeutics

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Sarepta Therapeutics
Price $83.33
Target Price Sign up
Market Cap $7.9B
Dividend Yield 0.0126
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23332M149M183M-41M-28M
Q2 '23261M119M142M-24M-9.2M
Q1 '23254M111M143M-517M-506M
Q4 '22258M123M135M-109M-94M
Q3 '22230M105M125M-258M-242M

Insider Transactions

INGRAM DOUGLAS S filed to buy 390,307 shares at $81.3.
November 6 '23
Barry Richard filed to buy 140,000 shares at $78.8.
November 6 '23
Chambers Michael Andrew filed to buy 246,996 shares at $109.9.
August 15 '23
Chambers Michael Andrew filed to buy 237,017 shares at $108.1.
August 14 '23
Chambers Michael Andrew filed to buy 213,331 shares at $106.3.
August 11 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.